[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367373-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367373-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","therapeutic-potentials-of-mirna-for-colorectal-cancer-liver-metastasis-treatment-a-narrative-review","Therapeutic Potentials of MiRNA for Colorectal Cancer Liver Metastasis Treatment - A Narrative Review","","Colorectal cancer (CRC) ranks among the most prevalent cancers worldwide and remains a major cause of cancer mortality, with liver metastasis driving a large share of deaths. Colorectal liver metastasis (CRLM) is common and limited by restricted surgical eligibility and frequent chemotherapy resistance, creating a need for more effective targeted options. MicroRNAs (miRNAs) regulate key CRLM pathways, including invasion, epithelial-mesenchymal transition, and angiogenesis, functioning as tumor suppressors and oncogenes through multi-gene targeting. This narrative review consolidates recent evidence to assess miRNAs for diagnostic, prognostic, and therapeutic potential, offering insights to guide future strategies and improve patient outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/therapeutic-potentials-of-mirna-for-colorectal-cancer-liver-metastasis-treatment-a-narrative-review/367373/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/therapeutic-potentials-of-mirna-for-colorectal-cancer-liver-metastasis-treatment-a-narrative-review/367373.png","ImageObject",300,407,{"name":42,"@type":43},"Jacob","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is colorectal liver metastasis a major obstacle in colorectal cancer treatment?","Question",{"text":63,"@type":64},"CRLM is a frequent cause of mortality, and standard therapies are constrained by limited surgical eligibility and common chemotherapy resistance. These factors reduce overall survival and highlight the need for better targeted treatments.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What roles do microRNAs (miRNAs) play in colorectal cancer liver metastasis?",{"text":68,"@type":64},"miRNAs modulate critical pathways involved in tumor invasion, epithelial-mesenchymal transition, and angiogenesis. They can act as tumor suppressors or oncogenes by targeting multiple genes, reflecting complex involvement in metastasis.",{"name":70,"@type":61,"acceptedAnswer":71},"What does this narrative review aim to provide for CRLM management?",{"text":72,"@type":64},"It consolidates current understanding of miRNA involvement in CRLM and evaluates their potential as diagnostic, prognostic, and therapeutic agents. The goal is to support future therapeutic strategies and improve patient outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367373,1790330319,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","IJMS  \nVol 50, No 4, April 2025  \nReview Article  \nTherapeutic Potentials of MiRNA for Colorectal Cancer Liver Metastasis Treatment:  \nA Narrative Review  \nAmir Hossein Barjasteh1, MD; Rawa  \nJaseb Mazhar AleKassar2 , PhD; Abdulridha Mohammed Al-Asady3,4,5,6 , PhD; Hanieh Latifi1, MD student; Amir Avan6,7, PhD; Majid Khazaei6,8 , PhD; Mikhail Ryzhikov9 , PhD; Seyed Mahdi Hassanian2 , PhD  \n1Metabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;  \n2Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;  \n3Department of Medical Sciences, Faculty of Nursing, Warith Al-Anbiyaa University, Iraq;  \n4Department of Medical Sciences, Faculty of Dentistry, University of Kerbala, Iraq;  \n5Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;  \n6Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; 7Faculty of Health, School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, QLD 4059, Australia;  \n8Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;  \n9Saint Louis University, School of Medicine, St. Louis, MO, USA  \nCorrespondence:  \nSeyed Mahdi Hassanian, PhD;  \nDepartment of Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Vakil Abad Blvd. , Mashhad, Iran  \nTel: +98 51 38002375  \nEmail: [hasanianmehrm@mums.ac.ir](hasanianmehrm@mums.ac.ir)  \n[Received: 24 June 2024](Received: 24 June 2024)  \n[Revised: 01 November 2024](Revised: 01 November 2024)  \n[Accepted: 26 November 2024](Accepted: 26 November 2024)  \n\n| \u003Cbr>What’s Known\u003Cbr>• Colorectal cancer (CRC), the third most common cancer globally, remains a significant cause of cancer mortality. Although advancements in surgical and chemoradiotherapy options exist, the challenges of treatment tolerance and adverse side effects persist, particularly in cases with liver metastasis.\u003Cbr>\u003Cbr>What’s New |\n| --- |\n| • MicroRNAs (miRNAs) have emerged as crucial players, influencing tumor progression and chemotherapy response and even in early diagnosis and prognosis of the metastasis of CRC to the liver.\u003Cbr>• This article providesan in-depth review of recent studies on miRNA-based approaches to enhance chemotherapy tolerance in CRC liver metastasis. As research on miRNAs in this area continues to expand, this review aims to present the current findings and explore miRNAs’ diagnostic and prognostic potentials, offering insights into their role in managing CRC liver metastasis and forming future therapeutic strategies. |\n\nAbstract  \nColorectal cancer (CRC) ranks among the most prevalent cancers worldwide and is the fourth leading cause of cancer-related deaths. Metastasis poses a significant obstacle in CRC treatment, as distant metastasis, particularly to the liver, remains the primary cause of mortality. Colorectal liver metastasis (CRLM) occurs frequently due to the liver’s direct vascular connection to the colorectal region via the portal vein. Standard treatment approaches for CRLM are limited; only a few patients qualify for surgical intervention, resulting in a persistently low survival rate. Additionally, resistance to chemotherapy is common, emphasizing the need for more effective targeted therapies. Emerging evidence highlights the pivotal role of microRNAs (miRNAs) in modulating critical pathways associated with CRLM, including tumor invasion, epithelial-mesenchymal transition, and angiogenesis. MiRNAs exhibit dual functions as tumor suppressors and oncogenes by targeting multiple genes, thus playing a complex role in both the initiation and progression of metastasis. The regulatory mechanisms of miRNAs could help to identify novel biomarkers for early diagnosis and prognosis of CRLM, as well as promising therapeutic targets to overcome chemoresistance. Despite numerous studies on miRN","cbCairyRomHw3xvD","https://ap.wps.com/l/cbCairyRomHw3xvD","pdf",1871791,18,"English","# What’s Known\n## Colorectal cancer and current challenges in liver metastasis treatment\n# What’s New\n## Emerging roles of microRNAs in CRC liver metastasis\n# Abstract\n# Introduction\n## Epidemiology and burden of colorectal cancer\n# Review Focus\n## miRNA involvement in CRLM diagnosis, prognosis, and therapeutics","[{\"question\":\"Why is colorectal liver metastasis a major obstacle in colorectal cancer treatment?\",\"answer\":\"CRLM is a frequent cause of mortality, and standard therapies are constrained by limited surgical eligibility and common chemotherapy resistance. These factors reduce overall survival and highlight the need for better targeted treatments.\"},{\"question\":\"What roles do microRNAs (miRNAs) play in colorectal cancer liver metastasis?\",\"answer\":\"miRNAs modulate critical pathways involved in tumor invasion, epithelial-mesenchymal transition, and angiogenesis. They can act as tumor suppressors or oncogenes by targeting multiple genes, reflecting complex involvement in metastasis.\"},{\"question\":\"What does this narrative review aim to provide for CRLM management?\",\"answer\":\"It consolidates current understanding of miRNA involvement in CRLM and evaluates their potential as diagnostic, prognostic, and therapeutic agents. The goal is to support future therapeutic strategies and improve patient outcomes.\"}]","Therapeutic Potentials of MiRNA for Colorectal Cancer Liver Metastasis Treatment - A Narrative Review | PDF",1790170508,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a06c0bfa1b43b68348b1073562b68b0.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/400988af76d420792cd1340ba7e491c9.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67635b23e982e4e9bd497aed416ec193.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff6df6fc9c8e3dee19fde22f5bb807aa.webp",980,1385]